Research News and Research

RSS

Researchers to develop effective mucosal vaccines based on cell-targeted nanoparticles

The Knut and Alice Wallenberg Foundation will give a little over SEK 16 million to the development of new, highly-efficient mucosal vaccines. The vaccines will be drinkable or given as a nasal spray. Professor Nils Lycke at MIVAC at the Sahlgrenska Academy will in cooperation with researchers at Chalmers University of Technology and Lund University, combine technologies to develop the next generation of effective mucosal vaccines based on immunomodulation and cell-targeted nanoparticles.

9 Oct 2013

Study reveals association between sleep-disordered breathing and Alzheimer's disease

Alzheimer's disease affects millions of people worldwide. As a result of an increase in life expectancy, the number of patients with dementia is expected to increase dramatically. Due to the lack of effective treatments that can slow down or reverse the progression of AD, preventive measures to lower the prevalence rate of AD by means of managing potential or actual risk factors is a reasonable clinical strategy.

9 Oct 2013

Supreme Court justices seek administration views in medical device case

The Supreme Court on Monday sought the legal views of the Obama administration in a medical device manufacturer's appeal of a ruling that the company can be sued by a man who was left paralyzed after using one of its products (Hurley, 10/7).

9 Oct 2013

Study looks at attitudes toward drug use among high school seniors

High school seniors who frown upon the use of drugs are most likely to be female, nonsmokers or hold strong religious beliefs, according to a study- by Joseph Palamar of New York University. Palamar examines how teenagers' attitudes toward marijuana influenced their thoughts on the further use of other illicit drugs.

9 Oct 2013

FAIR Health uses dental claims data from FH NPIC in recent report published by U.S. GAO

FAIR Health, the leading independent data company that serves the healthcare system through data tools and education, is pleased to announce the use of its dental claims data in the recent report published by the U.S. Government Accountability Office (GAO).

9 Oct 2013

Cost issues: Expensive patients; payoff from delaying aging; approving new treatments

Cost and quality issues in the news include research about the costliest U.S. patients, the potential that delaying aging instead of treating disease could have on extending life, and examining how the U.S. compares to other countries on approving new medical treatments.

9 Oct 2013

ProTip, Strasbourg University Hospitals complete first implantation of artificial larynx in human patient

ProTip SAS, the specialist developer of innovative medical devices for patients suffering from laryngeal malfunction, and Strasbourg University Hospitals today announce that they have successfully completed the first implantation of an artificial larynx in a human patient.

9 Oct 2013

Evaluate launches strategic sales analytics solution that provides global view of life sciences product sales

Evaluate Ltd. today announced the launch of a strategic sales analytics solution that provides commercial teams and the investment community with a comprehensive view of life sciences product sales by country.

9 Oct 2013

NeuroVigil opens satellite research lab at NASA to develop assistive technologies for ALS

NeuroVigil, Inc. is setting to collaborate with a number of partners in the Silicon Valley where it is opening a satellite research laboratory at NASA Research Park in Mountain View, CA, to develop assistive technologies for individuals suffering from ALS and other conditions affecting the central nervous system.

9 Oct 2013

Software crash in first days viewed as root cause of exchange delays

The New York Times reports that a major software component crashed under the pressure posed by millions of visitors last week to the federal online insurance marketplace. Still, other technical issues beyond traffic also are at work, and some insurers say they are getting faulty and incomplete data from the new U.S.-run health exchange.

9 Oct 2013

Extremely high level intensity of Tabata-style workouts may be effective for cardio fitness

Can an effective cardiovascular workout be done in 20 minutes or less? Depending on level of intensity, yes it can, according to a recent study of Tabata-style workouts commissioned by American Council on Exercise (ACE).

9 Oct 2013

New booklet helps researchers decide about conducting clinical trials in Asia-Pacific region

A new booklet from Theorem Clinical Research is now available to help researchers at medical device companies decide if they want to conduct clinical trials in the Asia-Pacific region, and, if so, in what countries.

9 Oct 2013

Senate Democrats ponder 'clean' debt limit bill; GOP holds Obamacare ground

Democratic leaders in the Senate are mulling passing a "clean" bill -- one with no other policy changes -- that would increase the nation's debt limit. House Republican leadership continues to refuse any proposal that doesn't strike some parts of the new health law. In the meantime, talk about the government shutdown sometimes ignores the health law's role in it.

9 Oct 2013

Report: Even states opting out of Medicaid expansion will see enrollees, costs rise

Media outlets reported on a Kaiser Family Foundation study that projected a 5 percent jump next year in the number of people enrolled in the state-federal insurance program for the poor, even in states that will not expand eligibility.

9 Oct 2013

Healios K.K. successfully raised its target capital of 3 billion JPY (USD $30.6 million)

Healios K.K. (Headquarters: Tokyo, Japan; President and CEO: Hardy TS Kagimoto M.D.), a Japanese bioventure company at the forefront of developing innovative therapies utilizing human induced pluripotent stem cell (hiPSC) technology, is pleased to announce that it has successfully raised its target capital of 3 billion JPY (USD $30.6 million).

9 Oct 2013

Report: States lax in taking steps to curb prescription drug abuse

The number of deaths attributed to the abuse of painkillers and other prescription drugs has risen sharply in recent years.

9 Oct 2013

Bayer HealthCare receives FDA approval for Adempas tablets

Bayer HealthCare announced today that the United States Food and Drug Administration has approved Adempas (riociguat) tablets for: (i) the treatment of adults with persistent/recurrent chronic thromboembolic pulmonary hypertension (WHO Group 4) after surgical treatment or inoperable CTEPH to improve exercise capacity and WHO functional class; and (ii) the treatment of adults with pulmonary arterial hypertension (WHO Group 1) to improve exercise capacity, improve WHO functional class and delay clinical worsening.

9 Oct 2013

Edimer doses first XLHED-affected neonate in Phase 2 trial of EDI200

Edimer Pharmaceuticals, a biotechnology company focused on developing an innovative therapy for the rare genetic disorder X-linked Hypohidrotic Ectodermal Dysplasia (XLHED), today announced the enrollment and completed dosing of the first XLHED-affected neonate in a Phase 2 trial of EDI200, the company's novel, proprietary, recombinant protein.

9 Oct 2013

Despite sales efforts, polls show continued Obamacare doubts

Even as states like California push the health law exchanges, bolstered by a growing list of celebrity pitchmen, surveys of some groups -- among them, physician practices and likely Virginia voters -- show continued doubts about the marketplaces.

9 Oct 2013

Quintiles and MDA partner to develop U.S. Neuromuscular Disease Registry

Quintiles and the Muscular Dystrophy Association (MDA) today announced a new partnership to develop and implement the U.S. Neuromuscular Disease Registry, a patient registry that will play an important role in determining effective treatments for people with muscular dystrophy and related muscle diseases.

9 Oct 2013

Research News and Research

Researchers to develop effective mucosal vaccines based on cell-targeted nanoparticles

Study reveals association between sleep-disordered breathing and Alzheimer's disease

Supreme Court justices seek administration views in medical device case

Study looks at attitudes toward drug use among high school seniors

FAIR Health uses dental claims data from FH NPIC in recent report published by U.S. GAO

Cost issues: Expensive patients; payoff from delaying aging; approving new treatments

ProTip, Strasbourg University Hospitals complete first implantation of artificial larynx in human patient

Evaluate launches strategic sales analytics solution that provides global view of life sciences product sales

NeuroVigil opens satellite research lab at NASA to develop assistive technologies for ALS

Software crash in first days viewed as root cause of exchange delays

Extremely high level intensity of Tabata-style workouts may be effective for cardio fitness

New booklet helps researchers decide about conducting clinical trials in Asia-Pacific region

Senate Democrats ponder 'clean' debt limit bill; GOP holds Obamacare ground

Report: Even states opting out of Medicaid expansion will see enrollees, costs rise

Healios K.K. successfully raised its target capital of 3 billion JPY (USD $30.6 million)

Report: States lax in taking steps to curb prescription drug abuse

Bayer HealthCare receives FDA approval for Adempas tablets

Edimer doses first XLHED-affected neonate in Phase 2 trial of EDI200

Despite sales efforts, polls show continued Obamacare doubts

Quintiles and MDA partner to develop U.S. Neuromuscular Disease Registry

Spectroscopy Applications in the Environment eBook eBook

Latest eBooks

Editorial Focus eBook - Proteomics (2nd Edition)

Industry Focus eBook - Life Science Microscopy (2nd Edition)

BFEB: Advances in microplate-based assays and analysis

Biologics stability screening toolkit: Three practical workflows for accelerating formulation development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery